vimarsana.com

Page 7 - Afirma Genomic Sequencing Classifier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Veracyte, Inc (NASDAQ:VCYT) Receives $30 60 Consensus Price Target from Brokerages

Veracyte, Inc (NASDAQ:VCYT) Receives $30 60 Consensus Price Target from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Clough Capital Partners L P Has $7 58 Million Position in Veracyte, Inc (NASDAQ:VCYT)

Clough Capital Partners L P boosted its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.3% in the first quarter, Holdings Channel reports. The firm owned 339,978 shares of the biotechnology company’s stock after purchasing an additional 23,002 shares during the period. Clough Capital Partners L P’s holdings in Veracyte were worth […]

44,583 Shares in Veracyte, Inc (NASDAQ:VCYT) Bought by Atom Investors LP

Atom Investors LP purchased a new position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 44,583 shares of the biotechnology company’s stock, valued at approximately $994,000. Atom Investors LP owned about 0.06% of […]

Veracyte, Inc (NASDAQ:VCYT) Receives Consensus Recommendation of Moderate Buy from Analysts

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company. […]

Champlain Investment Partners LLC Sells 37,100 Shares of Veracyte, Inc (NASDAQ:VCYT)

Champlain Investment Partners LLC cut its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 1.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 1,918,730 shares of the biotechnology company’s stock after selling 37,100 shares during the period. Champlain Investment Partners LLC’s holdings in Veracyte were worth $42,788,000 as of its most recent […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.